Basic Information
| RNALocate ID: | RLID:11003881 |
| RNA Symbol: | hsa-miR-362-3p |
| Localization: | Exosome |
RNA Information
| RNA Name: | hsa-miR-362-3p |
| RNA ID: | miRBase:MIMAT0004683 |
| RNA Category: | miRNA |
| Species: | Homo sapiens |
Localization Information
| PubMed ID: | 21505438 |
| Tissue/Cell Line: | Primary dendritic cells|T cell line (J77) |
| Method: | Microarray |
| Description: | Microarray analysis of exosomal miRNAs verses the miRNAs of their respective donor cells. Data are collected from Supplementary Data 1. |
Other Subcellular Localization
| RNALocate ID | Localization | Tissue/Cell line | PubMed ID |
| RLID:11003882 | Exosome | Plasma | 23663360 |
| RLID:11003883 | Exosome | Colon cancer cell line (LIM1863) | 25330373 |
| RLID-D:11000659 | Microvesicle | Colon cancer cell line (LIM1863)|Mesenchymal stem cells | |
| RLID-D:11001529 | Exosome | Breast milk|Cell lines|Epididymal epithelial cells|Osteoblast|Plasma|Primary glioblastoma neurosphere cells|Primary keratinocyte|Saliva|Serum|Urine |
ncRNA Disease Information
| Resource | RNA Symbol | Disease | Link |
| MNDR | hsa-miR-362-3p | Oral squamous cell carcinoma | MNDR-E-MI-43720 |
| MNDR | hsa-miR-362-3p | High-grade serous ovarian carcinoma | MNDR-E-MI-43721 |
| MNDR | hsa-miR-362-3p | Ovarian clear cell carcinoma | MNDR-E-MI-43722 |
| MNDR | hsa-miR-362-3p | Uterine corpus endometrial carcinoma | MNDR-E-MI-43723 |
| MNDR | hsa-miR-362-3p | Lymphoma | MNDR-E-MI-43724 |
| MNDR | hsa-miR-362-3p | Estrogen-receptor positive breast cancer | MNDR-E-MI-43725 |
| MNDR | hsa-miR-362-3p | Estrogen-receptor negative breast cancer | MNDR-E-MI-43726 |
| MNDR | hsa-miR-362-3p | Progesterone-receptor positive breast cancer | MNDR-E-MI-43727 |
| MNDR | hsa-miR-362-3p | Progesterone-receptor negative breast cancer | MNDR-E-MI-43728 |
| MNDR | hsa-miR-362-3p | Her2-receptor positive breast cancer | MNDR-E-MI-43729 |
| MNDR | hsa-miR-362-3p | Breast cancer luminal | MNDR-E-MI-43730 |
| MNDR | hsa-miR-362-3p | Prostate cancer | MNDR-E-MI-43731 |
| MNDR | hsa-miR-362-3p | Chronic lymphocytic leukemia | MNDR-E-MI-43732 |
| MNDR | hsa-miR-362-3p | Gastric cancer | MNDR-E-MI-43733 |
| MNDR | hsa-miR-362-3p | Alzheimer disease | MNDR-E-MI-43734 |
| MNDR | hsa-miR-362-3p | Intracranial aneurysm | MNDR-E-MI-43735 |
| MNDR | hsa-miR-362-3p | Esophageal carcinoma | MNDR-E-MI-43736 |
| MNDR | hsa-miR-362-3p | Dysautonomia familial | MNDR-E-MI-43737 |
| MNDR | hsa-miR-362-3p | Cardiovascular disease | MNDR-E-MI-43738 |
| MNDR | hsa-miR-362-3p | Lung cancer | MNDR-E-MI-43739 |
| MNDR | hsa-miR-362-3p | Parkinson disease | MNDR-E-MI-43740 |
| MNDR | hsa-miR-362-3p | Basal-like breast cancer | MNDR-E-MI-43741 |
| MNDR | hsa-miR-362-3p | Pancreatic cancer | MNDR-E-MI-43742 |
| MNDR | hsa-miR-362-3p | Melanoma | MNDR-E-MI-43743 |
| MNDR | hsa-miR-362-3p | Nephroblastoma | MNDR-E-MI-43744 |
| MNDR | hsa-miR-362-3p | Colon adenocarcinoma | MNDR-E-MI-43745 |
| MNDR | hsa-miR-362-3p | Relapsing-remitting multiple sclerosis | MNDR-E-MI-43746 |
| MNDR | hsa-miR-362-3p | Familial ovarian cancer | MNDR-E-MI-43747 |
| MNDR | hsa-miR-362-3p | Carcinoma ductal breast | MNDR-E-MI-43748 |
| MNDR | hsa-miR-362-3p | Glioblastoma | MNDR-E-MI-43749 |
| MNDR | hsa-miR-362-3p | Glioma | MNDR-E-MI-43750 |
| MNDR | hsa-miR-362-3p | Amyotrophic lateral sclerosis | MNDR-E-MI-43751 |
| MNDR | hsa-miR-362-3p | Temporal lobe epilepsy | MNDR-E-MI-43752 |
| MNDR | hsa-miR-362-3p | Osteosarcoma | MNDR-E-MI-43753 |
| MNDR | hsa-miR-362-3p | Middle cerebral artery infarction | MNDR-E-MI-43754 |
| MNDR | hsa-miR-362-3p | Cervical adenocarcinoma | MNDR-E-MI-43755 |
| MNDR | hsa-miR-362-3p | Gastric adenocarcinoma | MNDR-E-MI-43756 |
| MNDR | hsa-miR-362-3p | Lung squamous cell carcinoma | MNDR-E-MI-43757 |
| MNDR | hsa-miR-362-3p | Lung adenocarcinoma | MNDR-E-MI-43758 |
| MNDR | hsa-miR-362-3p | Papillary thyroid carcinoma | MNDR-E-MI-43759 |
| MNDR | hsa-miR-362-3p | Ovarian carcinoma | MNDR-E-MI-43760 |
| MNDR | hsa-miR-362-3p | Bladder urothelial carcinoma | MNDR-E-MI-43761 |
| MNDR | hsa-miR-362-3p | Pancreatic adenocarcinoma | MNDR-E-MI-43762 |
| MNDR | hsa-miR-362-3p | Kidney renal clear cell carcinoma | MNDR-E-MI-43763 |
| MNDR | hsa-miR-362-3p | Kidney renal papillary cell carcinoma | MNDR-E-MI-43764 |
| MNDR | hsa-miR-362-3p | Renal clear cell carcinoma | MNDR-E-MI-43765 |
| MNDR | hsa-miR-362-3p | Cholangiocarcinoma | MNDR-E-MI-43766 |
| MNDR | hsa-miR-362-3p | Head and neck squamous cell carcinoma | MNDR-E-MI-43767 |
| MNDR | hsa-miR-362-3p | Breast invasive carcinoma | MNDR-E-MI-43768 |
| MNDR | hsa-miR-362-3p | Hepatocellular carcinoma | MNDR-E-MI-43769 |
| MNDR | hsa-miR-362-3p | Familiar ovarian carcinoma | MNDR-E-MI-43770 |
| MNDR | hsa-miR-362-3p | B-cell lymphoma | MNDR-E-MI-43771 |
| MNDR | hsa-miR-362-3p | Malignant pleural mesothelioma | MNDR-E-MI-43772 |
| MNDR | hsa-miR-362-3p | Retinoblastoma | MNDR-E-MI-43773 |
| MNDR | hsa-miR-362-3p | Hodgkin lymphoma | MNDR-E-MI-43774 |
| MNDR | hsa-miR-362-3p | Acute myeloid leukemia | MNDR-E-MI-43775 |
| MNDR | hsa-miR-362-3p | Colorectal cancer | MNDR-E-MI-43776 |
| MNDR | hsa-miR-362-3p | Nasopharynx carcinoma | MNDR-E-MI-43777 |
| MNDR | hsa-miR-362-3p | Multiple myeloma | MNDR-E-MI-43778 |
| MNDR | hsa-miR-362-3p | Nasopharyngeal cancer | MNDR-E-MI-43779 |
RNA Interaction Information
| Resource | RNA Symbol | Species | Link | RNALocate ID |
| RNAInter | BCAR1 | Homo sapiens | RR00217445 |
TOP